uniQure N.V.
QURE
Market Cap$758.81M
Close$
$-2.76
119.8% downside
Current Fair Value
119.8% downsideOvervalued by 119.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $758.81 Million |
|---|---|
| Enterprise Value | $613.05 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-4.92 |
| Beta | 0.09 |
| Outstanding Shares | 53,110,580 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.38 |
|---|---|
| PEG | 10.1 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 30.35 |
| Enterprise Value to EBIT | -3.33 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 2.12 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About uniQure N.V.
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary gene therapies to tr...